The OPT2MISE Study – A Review of the Major Findings and Clinical Implications
Open Access
- 1 January 2015
- journal article
- review article
- Published by Touch Medical Media, Ltd. in touchREVIEWS in Endocrinology
- Vol. 11 (2), 70-74
- https://doi.org/10.17925/EE.2015.11.02.70
Abstract
Many patients with type 2 diabetes struggle to achieve adequate glucose control despite escalation of therapy including complex insulin regimens with multiple daily injections (MDIs). Previous randomised controlled trials failed to show a significant improvement in glycaemic control with pump therapy over multiple injections. The OPT2MISE study enrolled 495 adult patients with poorly controlled type 2 diabetes despite an intensified insulin regimen using rapid and slow-acting insulin analogues. After a 2-month run-in period, patients were randomised to switch to pump therapy or to maintain their MDI regimen. After 6 months, patients with pump therapy achieved a better glycaemic control than those who used multiple injections (glycated haemoglobin [HbA1c] difference of -0.7 %), and twice as many patients reached the target range of 8 % or less in the pump-therapy group compared with the injection group. Patients using pump therapy had a 20 % reduction of their total daily insulin dose. A moderate weight gain was observed with both treatments, and no severe hypoglycaemia nor ketoacidosis occurred in the pump therapy group. Pump therapy may now be considered as a valuable option in type 2 diabetes patients who fail to respond to an intensified insulin regimen.Keywords
This publication has 23 references indexed in Scilit:
- Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of DiabetesDiabetes Care, 2014
- Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 DiabetesDiabetes Care, 2014
- Benefits of exenatide on obesity and non‐alcoholic fatty liver disease with elevated liver enzymes in patients with type 2 diabetesDiabetes/Metabolism Research and Reviews, 2014
- Autonomy of Patients With Type 2 Diabetes With an Insulin Pump DeviceJournal of Diabetes Science and Technology, 2014
- Efficacy of Continuous Subcutaneous Insulin Infusion in Type 2 Diabetes Mellitus: A Survey on a Cohort of 102 Patients with Prolonged Follow-UpDiabetes Technology & Therapeutics, 2010
- Reduction of Glycosylated Hemoglobin Following 6 Months of Continuous Subcutaneous Insulin Infusion in an Indian Population with Type 2 DiabetesDiabetes Technology & Therapeutics, 2009
- Advancing Insulin Therapy in Type 2 Diabetes Previously Treated With Glargine Plus Oral AgentsDiabetes Care, 2008
- Treatment with intravenous insulin followed by continuous subcutaneous insulin infusion improves glycaemic control in severely resistant Type 2 diabetic patientsDiabetic Medicine, 2003
- One month's insulin treatment of type II diabetes: The early and medium-term effects following insulin withdrawalMetabolism, 1986
- The Effect of Insulin Treatment on Insulin Secretion and Insulin Action in Type II Diabetes MellitusDiabetes, 1985